发明名称 LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS
摘要 This invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntington's disease (HD), comprising administering to the patient laquinimod as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and pridopidine for treating a patient afflicted with a neurodegenerative disorder, e.g., HD. This invention also provides laquinimod for use as an add-on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder, e.g., HD. This invention further provides use of laquinimod and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder, e.g., HD.
申请公布号 EP2900330(A1) 申请公布日期 2015.08.05
申请号 EP20130840841 申请日期 2013.09.27
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 HAYDEN, MICHAEL
分类号 A61P25/00;A61K31/451;A61K31/4704;A61P25/18;A61P25/28 主分类号 A61P25/00
代理机构 代理人
主权项
地址